According to Gram Research analysis, a compound called apigenin-7-O-glucoside from the traditional Chinese herb formula Gualou-Xiebai activates a cellular cleanup process that removes excess fat from blood vessel cells and reduces atherosclerotic plaque formation in mice. In a 2026 study, this herb-derived compound stabilized the Rab7 protein, which triggered lipophagy—a specialized cellular cleanup mechanism that prevents harmful fat accumulation in blood vessel walls. While these findings are promising for future heart disease treatments, human clinical trials are still needed to confirm safety and effectiveness.

Researchers discovered how a traditional Chinese herb combination called Gualou-Xiebai might protect against atherosclerosis, a condition where fatty deposits build up in arteries. The study found that a specific compound in the herbs activates a cellular cleanup process that prevents harmful fat buildup in blood vessel cells. When tested in mice with atherosclerosis, the herb formula reduced plaque formation and improved cholesterol levels. This research suggests that compounds from traditional medicine could lead to new treatments for heart disease, though human studies are still needed to confirm these findings.

Key Statistics

A 2026 research study found that apigenin-7-O-glucoside, the primary active compound in the traditional herb formula Gualou-Xiebai, directly binds to and stabilizes the Rab7 protein to activate lipophagy, a cellular fat-removal process that reduces atherosclerotic plaque formation in mice.

In laboratory experiments, the herb formula Gualou-Xiebai improved dyslipidemia and reduced plaque burden in genetically modified atherosclerotic mice, with the protective effects completely eliminated when researchers blocked the cellular cleanup process using chloroquine.

Among three active compounds tested from the Gualou-Xiebai herb formula, apigenin-7-O-glucoside showed the strongest engagement with the Rab7 protein, while kaempferol and luteolin-7-O-gentiobioside demonstrated markedly weaker interactions.

When researchers artificially increased Rab7 levels in atherosclerotic mice, it stabilized plaques, improved lipid profiles, and enhanced autophagy in atherosclerotic lesions, confirming the protein’s central role in the herb’s protective mechanism.

The Quick Take

  • What they studied: How a traditional Chinese herb formula called Gualou-Xiebai and its active compounds prevent the buildup of fatty deposits in blood vessel walls that lead to heart disease.
  • Who participated: The study used genetically modified mice prone to atherosclerosis (ApoE-deficient mice) that were fed a high-fat diet for 12 weeks to develop heart disease, then treated with the herb formula for 4 additional weeks. Laboratory experiments also used human blood vessel cells exposed to harmful oxidized cholesterol.
  • Key finding: The herb formula, particularly a compound called apigenin-7-O-glucoside, activated a cellular cleanup process that removed excess fat from blood vessel cells and reduced plaque buildup in atherosclerotic mice.
  • What it means for you: This research suggests that compounds from traditional herbs might eventually lead to new heart disease treatments, but these findings are from animal and lab studies only. People should not replace current heart disease medications with herbal supplements without consulting their doctor.

The Research Details

Researchers created atherosclerosis in mice by feeding them a high-fat diet for 12 weeks, which caused fatty plaques to build up in their arteries. They then gave some mice the traditional herb formula Gualou-Xiebai for 4 weeks while monitoring changes in their arteries using ultrasound imaging and tissue analysis. In parallel, they studied how the herb worked at the cellular level using human blood vessel cells grown in the laboratory and exposed to harmful oxidized cholesterol. The researchers used advanced molecular techniques to identify exactly which compound in the herb formula was responsible for the protective effects and how it worked inside cells.

The study employed multiple sophisticated methods to trace the herb’s effects. They used genetic engineering to increase levels of a specific protein called Rab7 in mice to confirm it was important for the herb’s benefits. They also used mass spectrometry and other molecular techniques to identify which herb compounds directly bound to Rab7 and activated the cellular cleanup process. This multi-layered approach helped establish a clear chain of cause-and-effect from the herb compound to the protective effects observed in the mice.

The researchers validated their findings by blocking the cellular cleanup process with a drug called chloroquine, which eliminated the herb’s protective effects. This confirmed that the cleanup process was essential for how the herb worked. They also tested whether silencing the Rab7 gene would prevent the herb from working, which it did, further confirming the importance of this protein in the herb’s mechanism.

Understanding how traditional herbs work at the molecular level can help scientists develop new medications for heart disease. Rather than dismissing traditional medicine, this research shows how modern science can identify the active compounds and mechanisms behind traditional remedies. This approach could lead to more effective treatments with fewer side effects than current options.

This study used rigorous scientific methods including animal models, cell culture experiments, genetic manipulation, and advanced molecular analysis techniques. The researchers confirmed their findings using multiple independent methods (molecular docking, surface plasmon resonance, co-immunoprecipitation, and others), which strengthens confidence in the results. However, the study was conducted in mice and laboratory cells, not humans, so the findings need to be validated in human clinical trials before being used as a treatment. The research was published in a peer-reviewed journal focused on plant-based medicines, indicating it underwent expert review.

What the Results Show

The herb formula Gualou-Xiebai improved cholesterol levels and reduced the size of fatty plaques in mice with atherosclerosis. When researchers analyzed the mice’s genes, they found that the herb activated pathways related to cellular cleanup (autophagy) and lipid metabolism, with a protein called Rab7 playing a central role. When they artificially increased Rab7 levels in mice, it stabilized plaques, improved lipid profiles, and enhanced the cellular cleanup process in atherosclerotic lesions.

The researchers identified apigenin-7-O-glucoside (Api-7-O-G) as the main active compound in the herb formula responsible for these effects. This compound directly bound to and stabilized the Rab7 protein, which then activated a cellular cleanup process called lipophagy. Lipophagy is essentially the cell’s way of breaking down and recycling excess fat, preventing harmful accumulation. When researchers tested this compound on human blood vessel cells exposed to harmful oxidized cholesterol, it restored the cellular cleanup process and prevented fat from building up inside the cells.

Critically, when researchers blocked the cellular cleanup process with the drug chloroquine, both the herb formula and the Rab7 protein lost their protective effects. This proved that the cleanup process was absolutely essential for how the treatment worked. The research also showed that Rab7 works by engaging another protein called SNAP29 to help fuse cellular compartments, which is necessary for the cleanup process to function properly.

Two other compounds in the herb formula—kaempferol and luteolin-7-O-gentiobioside—also engaged with Rab7, but much more weakly than apigenin-7-O-glucoside. This suggests that while the herb formula contains multiple active compounds, one compound is primarily responsible for the protective effects. The research also demonstrated that the cellular cleanup process (lipophagy) specifically targets and removes excess lipids, distinguishing it from general cellular cleanup processes.

This research builds on existing knowledge that cellular cleanup processes are important for preventing atherosclerosis. Previous studies showed that autophagy (cellular cleanup) is impaired in atherosclerosis, but this study specifically identifies how a traditional herb activates a specialized form of cleanup (lipophagy) that targets fat. The research also connects traditional Chinese medicine to modern molecular biology, validating the clinical use of Gualou-Xiebai for chest pain conditions while explaining the mechanism. This approach of identifying active compounds in traditional herbs is increasingly common in modern drug discovery.

The most significant limitation is that all experiments were conducted in mice and laboratory cells, not humans. Mice models of atherosclerosis don’t perfectly replicate human heart disease. The study did not specify the exact number of mice used in each experiment, making it difficult to assess statistical power. The research focused on identifying the mechanism rather than testing whether the herb formula is safe and effective in humans. Additionally, the study used very high concentrations of the herb in mice (3-12 g/kg), which may not translate directly to human dosing. The research also did not examine potential side effects or interactions with other medications. Finally, while the study identified apigenin-7-O-glucoside as the main active compound, it did not test whether this isolated compound alone would be as effective as the whole herb formula in humans.

The Bottom Line

Based on this research, apigenin-7-O-glucoside and the herb formula Gualou-Xiebai show promise as potential treatments for atherosclerosis and heart disease. However, these findings are from animal and laboratory studies only. Confidence level: LOW for human application at this time. People with heart disease should continue taking prescribed medications and consult their cardiologist before adding any herbal supplements. Future human clinical trials are needed to determine safe and effective doses, potential side effects, and whether these compounds actually prevent heart disease in people.

This research is most relevant to cardiologists, pharmaceutical researchers, and companies developing new heart disease treatments. People with atherosclerosis or family history of heart disease may find this research interesting as a potential future treatment option, but should not change their current treatment based on these findings. Traditional medicine practitioners may be interested in the scientific validation of Gualou-Xiebai’s mechanism. People taking blood thinners or other heart medications should definitely consult their doctor before using any herbal supplements, as interactions are possible.

In the mice studied, the herb formula showed effects after 4 weeks of treatment. However, translating this to humans is uncertain. If human clinical trials are conducted, it typically takes 5-10 years to move from promising laboratory findings to approved medications. People should not expect immediate results from herbal supplements and should maintain realistic expectations about the timeline for new treatments to become available.

Frequently Asked Questions

Can I take Gualou-Xiebai herb formula to prevent heart disease?

This herb formula shows promise in animal studies, but human clinical trials haven’t been conducted yet. Current heart disease medications have proven effectiveness in humans. Consult your cardiologist before adding any herbal supplements, as they may interact with your medications. Don’t replace prescribed treatments with unproven herbal remedies.

What is lipophagy and why does it matter for heart disease?

Lipophagy is a cellular cleanup process that removes excess fat from inside cells. In atherosclerosis, blood vessel cells accumulate harmful fat, forming plaques that narrow arteries. By activating lipophagy, the herb compound helps cells eliminate excess fat before it causes damage, potentially preventing plaque formation.

How long would it take for this herb treatment to work if it were approved for humans?

In mice, the herb showed effects after 4 weeks of treatment. However, human bodies work differently than mouse bodies, and dosing would need to be determined through clinical trials. If approved, it could take several years of research before this becomes an available treatment option for patients.

Is apigenin-7-O-glucoside available as a supplement I can buy now?

Apigenin-7-O-glucoside is a specific compound found in the Gualou-Xiebai herb formula, but isolated supplements of this compound are not widely available for human use. The research is still in early stages. Any herbal products claiming to contain this compound should be discussed with your doctor before use.

Why do researchers study traditional Chinese herbs for modern diseases?

Traditional herbs have been used clinically for centuries, suggesting they contain active compounds. Modern science can identify these compounds and understand how they work at the molecular level. This approach has led to many approved medications and may reveal new treatments for diseases like heart disease.

Want to Apply This Research?

  • Track daily cholesterol levels (if monitoring at home) and arterial health markers alongside any herbal supplement use. Record the specific supplement name, dose, and time taken. Note any changes in chest pain, shortness of breath, or other heart-related symptoms. Compare these metrics monthly to identify patterns.
  • If a user is interested in this research, they could use the app to: (1) set reminders to take prescribed heart medications consistently, (2) log any herbal supplements they’re considering with their doctor’s approval, (3) track cardiovascular risk factors like cholesterol, blood pressure, and weight, and (4) record discussions with their cardiologist about emerging treatments like plant-based compounds.
  • Establish a baseline of current cardiovascular health metrics (cholesterol, blood pressure, weight, exercise capacity). If a user begins any new supplement regimen with doctor approval, track these same metrics weekly or monthly to identify any changes. Use the app to maintain a log of all supplements and medications taken, including dates and doses, to share with healthcare providers. Set quarterly check-in reminders to review progress with a cardiologist.

This research describes findings from animal studies and laboratory experiments, not human clinical trials. The herb formula Gualou-Xiebai and its compounds have not been approved by the FDA for treating atherosclerosis or heart disease in humans. Do not use herbal supplements to replace prescribed heart disease medications without consulting your cardiologist. Some herbal products may interact with blood thinners, statins, and other cardiovascular medications. Pregnant women, nursing mothers, and people with certain medical conditions should avoid herbal supplements unless approved by their healthcare provider. This article is for educational purposes only and should not be considered medical advice. Always consult with a qualified healthcare professional before starting any new supplement regimen, especially if you have existing heart disease or take prescription medications.

This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.

Source: Gualou-Xiebai-derived Apigenin-7-O-glucoside inhibits VSMCs foam cell formation and alleviates atherosclerosis by targeting Rab7 to drive SNAP29-dependent lipophagy.Phytomedicine : international journal of phytotherapy and phytopharmacology (2026). PubMed 42623952 | DOI